Simon H. Anderson

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

Fecal loss of vedolizumab is associated with ulcerative colitis severity, lower serum vedolizumab levels, and rates of clinical response: results from the FAVOUR study.

Fecal loss of vedolizumab is associated with ulcerative colitis severity, lower serum vedolizumab levels, and rates of clinical response: results from the FAVOUR study.

Journal: Journal of Crohn's & colitis
Published: September 02, 2025

Factors predicting conversion from colon capsule endoscopy to conventional optical endoscopy-findings from the CESCAIL study.

Factors predicting conversion from colon capsule endoscopy to conventional optical endoscopy-findings from the CESCAIL study.

Journal: BMC gastroenterology
Published: November 02, 2024

Vibrational exercise for Crohn's to observe response (VECTOR): Protocol for a randomized controlled trial.

Vibrational exercise for Crohn's to observe response (VECTOR): Protocol for a randomized controlled trial.

Journal: PloS one
Published: November 01, 2024

Amoebic colitis masquerading as inflammatory bowel disease for a decade.

Amoebic colitis masquerading as inflammatory bowel disease for a decade.

Journal: The New Zealand medical journal
Published: April 13, 2023

Correction to: Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease: a retrospective multi-centre study in the United Kingdom.

Correction to: Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease: a retrospective multi-centre study in the United Kingdom.

Journal: BMC gastroenterology
Published: April 27, 2022

A retrospective cohort study: pre-operative oral enteral nutritional optimisation for Crohn's disease in a UK tertiary IBD centre.

A retrospective cohort study: pre-operative oral enteral nutritional optimisation for Crohn's disease in a UK tertiary IBD centre.

Journal: Alimentary pharmacology & therapeutics
Published: December 20, 2021

Depression, anxiety, and stress among inflammatory bowel disease patients during COVID-19: A UK cohort study.

Depression, anxiety, and stress among inflammatory bowel disease patients during COVID-19: A UK cohort study.

Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: May 19, 2021

An observational study of switching infliximab biosimilar: no adverse impact on inflammatory bowel disease control or drug levels with first or second switch.

An observational study of switching infliximab biosimilar: no adverse impact on inflammatory bowel disease control or drug levels with first or second switch.

Journal: Alimentary pharmacology & therapeutics
Published: March 02, 2021

Relationship Between Thiopurine S-Methyltransferase Genotype/Phenotype and 6-Thioguanine Nucleotide Levels in 316 Patients With Inflammatory Bowel Disease on 6-Thioguanine.

Relationship Between Thiopurine S-Methyltransferase Genotype/Phenotype and 6-Thioguanine Nucleotide Levels in 316 Patients With Inflammatory Bowel Disease on 6-Thioguanine.

Journal: Therapeutic drug monitoring
Published: December 01, 2020

The effects of COVID-19 on IBD prescribing and service provision in a UK tertiary centre.

The effects of COVID-19 on IBD prescribing and service provision in a UK tertiary centre.

Journal: GastroHep
Published: August 11, 2020

Managing an IBD Infusion Unit During the COVID-19 Pandemic: Service Modifications and the Patient Perspective.

Managing an IBD Infusion Unit During the COVID-19 Pandemic: Service Modifications and the Patient Perspective.

Journal: Inflammatory bowel diseases
Published: June 28, 2020

Tofacitinib in Acute Severe Ulcerative Colitis-A Real-World Tertiary Center Experience.

Tofacitinib in Acute Severe Ulcerative Colitis-A Real-World Tertiary Center Experience.

Journal: Inflammatory bowel diseases
Published: June 23, 2020
Showing 1-12 of 33

Last Updated: 09/26/2026